Solutions

Generic-drug CROs

Short, focused trials at scale — pricing and tooling aligned to how generic-drug development actually operates in India.

Per-study or per-month subscription, no per-form fees.

Rapid study setup for repeat protocol designs across formulations.

Multi-study oversight across the portfolio on a single data model.

DPDP Act 2023

Aligned by design

Schedule Y

CDSCO-aligned by design

ISO 27001

Information security controls aligned

Other ways teams use Trialion

Built-in PK sampling schedules, replicate-design support, and ANDA-ready exports — for the segment where India leads global study volume.

Phase II to IV across therapeutic areas — same data model, configurable workflows, one continuous audit trail.

Sponsor-grade quality, DPDP-aligned, and CDSCO submission support — without disrupting the global team's tooling.